Delivery Order SPE2DR25D3301-SPE2DR26F20AR
Award Date 12/30/25
Potential Completion Date 1/22/26
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 mg inhalation capsules (60-count package) valued at $1,294.24 under a firm fixed price arrangement. The award, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60 count) valued at $1,941.36 under a firm fixed price contract type. This award, issued on July 24, 2025, represents a non-competitive, non-set-aside transaction with an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,941.36 for INBRIJA 42 mg inhalation capsules (60-count) by the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a firm fixed-price, competitively awarded procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,132.50 to AmerisourceBergen Drug Corp for INBRIJA 42 mg inhalation capsules (60-count) on December 18, 2025, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $1,941.36 delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 mg Inhalation Capsules (60-count) on August 25, 2025, with completion scheduled for September 16, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The award was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count units) with a ceiling value of $1,879.50. This non-set-aside, firm fixed-price delivery order was competitively awarded on November 25, 2025, with an ultimate completion date of December 17, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of INBRIJA 42 mg inhalation capsules (60-count units) with a ceiling value of $1,941.36. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by May 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency has awarded a delivery order valued at $1,294.24 to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count), with an ultimate completion date of November 26, 2025. This non-set-aside competitive award was issued on November 4, 2025, under firm fixed pricing terms. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Inbrija 42 mg inhalation capsules (60-count package) under a firm fixed-price contract with a ceiling value of $1,879.50. This competitive award, with no set-aside designation, utilizes the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,876.50 to Amerisourcebergen Drug Corporation for the supply of 60 packages containing 42 mg capsules of INBRIJA, an inhalation drug used to treat Parkinson's disease symptoms. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning late September through mid-October of 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of...